Terms: = Breast cancer AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9 AND Treatment
6 results:
1. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Ko JM; Ning L; Zhao XK; Chai AWY; Lei LC; Choi SSA; Tao L; Law S; Kwong A; Lee NP; Chan KT; Lo A; Song X; Chen PN; Chang YL; Wang LD; Lung ML
Int J Cancer; 2020 Feb; 146(4):1042-1051. PubMed ID: 31396961
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic Discrimination of breast cancer Subtypes at the Single-Cell Level by Multiple Microextraction Coupled with Mass Spectrometry.
Wang R; Zhao H; Zhang X; Zhao X; Song Z; Ouyang J
Anal Chem; 2019 Mar; 91(5):3667-3674. PubMed ID: 30702862
[TBL] [Abstract] [Full Text] [Related]
3. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting mllt3.
Meng FJ; Meng FM; Wu HX; Cao XF
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
[TBL] [Abstract] [Full Text] [Related]
4. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
[TBL] [Abstract] [Full Text] [Related]
5. CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines.
Pobst LJ; Ames MM
Cancer Chemother Pharmacol; 2006 May; 57(5):569-76. PubMed ID: 16096788
[TBL] [Abstract] [Full Text] [Related]
6. [Development of a monoclonal antibody (af9) to human breast carcinoma].
Zeng W; Cai G; Cai M; Chen P; Wang C; Wei D; Chen G
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Dec; 25(4):380-3. PubMed ID: 7744377
[TBL] [Abstract] [Full Text] [Related]
